Why the study?
Extensive research has examined paraoxonase 1 mechanisms across various diseases, prompting a review focused specifically on the relationship between paraoxonase 1 and cancer.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
PON1-cancer link via oxidative stress and inflammation is hypothesis-generating; leaves open therapeutic targeting pending mechanistic trials.
Extensive research has been carried out to understand and elucidate the mechanisms of paraoxonase 1 (PON1) in the development of diseases including cancer, cardiovascular diseases, neurological diseases, and inflammatory diseases. This review focuses on the relationship between PON1 and cancer. The data suggest that PON1, oxidative stress, chronic inflammation, and cancer are closely linked. Certainly, the gene expression of PON1 will remain challenging to study. Therefore, targeting PON1, redox-sensitive pathways, and transcription factors promise prevention and therapy in the development of several diseases, including cancer.
No takes yet. Share an insight, caveat, or question.
Medina‐Díaz et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: